Elsa Gorre

Johnson & Johnson (United States)

Papers

1

Total Citations

24

H-Index

1

About

Elsa Gorre is a leading innovator in the field of biopharmaceutical analysis, with a primary focus on advancing high-throughput mass spectrometry for the characterization of biotherapeutics. Her most celebrated work, the 2023 paper “Lab of the Future”─Today: Fully Automated System for High-Throughput Mass Spectrometry Analysis of Biotherapeutics, has already garnered 24 citations, signaling its profound impact on the industry. In this landmark study, Gorre and her team designed and validated a fully integrated, multi-instrument automated system that seamlessly combines liquid and microplate handling robotics with LC-MS instrumentation and sophisticated data analysis software. This breakthrough effectively eliminates manual bottlenecks, enabling the rapid, reproducible, and high-quality analysis of complex biologic drugs. Her contributions are pivotal in accelerating drug development pipelines, reducing costs, and enhancing the reliability of critical quality attribute assessments. By transforming the traditional, labor-intensive laboratory into a streamlined, automated “Lab of the Future,” Elsa Gorre is setting a new standard for efficiency and precision in biotherapeutic characterization, making her a key figure in the ongoing digital transformation of pharmaceutical research.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
“Lab of the Future”─Today: Fully Automated System for High-Throughput Mass Spectrometry Analysis of Biotherapeutics
24 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago